Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in Relapsed or Refractory Mantle Cell Lymphoma
NCT03235544Phase 2Completed
- Sponsor
- Incyte
- Start
- Nov 2017
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of parsaclisib in mantle cell lymphoma (MCL), sponsored by Incyte. Started Nov 2017; status: completed.
02
Drugs
parsaclisib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT03235544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235544.